Complexo Hospitalario Universitario de Vigo
Centro de atención
Vicente
Estrada Pérez
Publicacións nas que colabora con Vicente Estrada Pérez (28)
2023
-
Hydroxychloroquine and Mortality in SARS-Cov-2 Infection; the HOPE-Covid-19 Registry
Anti-Infective Agents, Vol. 21, Núm. 2, pp. 66-78
2022
-
Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry
International Journal of Clinical Practice, Vol. 2022
-
Discovering HIV related information by means of association rules and machine learning
Scientific Reports, Vol. 12, Núm. 1
-
Epidemiological trends of HIV/HCV coinfection in Spain, 2015–2019
HIV Medicine, Vol. 23, Núm. 7, pp. 705-716
-
Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort
HIV Medicine, Vol. 23, Núm. 8, pp. 825-836
-
Predictors of poor prognosis in healthy, young, individuals with SARS-CoV-2 infections
Clinical Microbiology and Infection, Vol. 28, Núm. 2, pp. 273-278
2021
-
Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19])
Critical Care Medicine, Vol. 49, Núm. 6, pp. E624-E633
-
COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study
HIV Medicine, Vol. 22, Núm. 9, pp. 867-876
-
Impact of smoking on COVID-19 outcomes: A HOPE Registry subanalysis
BMJ Nutrition, Prevention and Health, Vol. 4, Núm. 1, pp. 285-292
-
Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry
Internal and Emergency Medicine, Vol. 16, Núm. 4, pp. 957-966
-
Prognostic factors at admission on patients with cancer and COVID-19: Analysis of HOPE registry data
Medicina Clinica, Vol. 157, Núm. 7, pp. 318-324
-
Redefining therapeutic success in HIV patients: An expert view
Journal of Antimicrobial Chemotherapy, Vol. 76, Núm. 10, pp. 2501-2518
-
Underlying heart diseases and acute covid-19 outcomes
Cardiology Journal, Vol. 28, Núm. 2, pp. 202-214
2020
-
Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study
The Lancet HIV, Vol. 7, Núm. 8, pp. e565-e573
-
Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry
Journal of Nephrology, Vol. 33, Núm. 4, pp. 737-745
2016
-
Executive summary: Prevención y tratamiento de infecciones oportunistas y otras coinfecciones en pacientes infectados por el VIH: mayo de 2015
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, Núm. 8, pp. 517-523
-
Improvement of lipoatrophy by switching from efavirenz to lopinavir/ritonavir
HIV Medicine, Vol. 17, Núm. 5, pp. 340-349
-
Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, Núm. 8, pp. 516.e1-516.e18
2015
-
Cardiovascular risk factors and lifetime risk estimation in hiv-infected patients under antiretroviral treatment in Spain
HIV Clinical Trials, Vol. 16, Núm. 2, pp. 57-65
-
Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): A randomised, open-label, non-inferiority trial
The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 785-792